A biopharmaceutical company that operates in one segment, the development of novel cell-based therapeutics designed to treat human diseases and disorders.


Updates from The Motley Fool

Latest updates on StemCells from Fool.com.
Tomorrow's Monster Stock?

A list of promising companies chosen by investors who've already picked stocks that beat the mark...

These Underdogs Are No Dogs

Like the smart hedge fund operators, these CAPS investors bet against a stock -- and won big.

Tomorrow's Monster Stock

These companies were chosen by investors who've already picked stocks that beat the market handily.

The Mice Can Walk!

Too bad there's no market for curing their paralysis.

A 1-in-100 Investor

CAPS members who score 100 points in 100 days have become some of the best investors around.

A Stem-Cell Primer

Public funding from states could help the companies doing the research.



Stock Performance

View Interactive MBOT Charts
Sponsored by

Key Data Points

Primary metrics and data points about StemCells.
Current Price: $6.22
Prev Close: $6.20
Open: $6.13
Bid: $6.19
Ask: $6.25
Day's Range: $6.07 - $6.25
52wk Range: $2.97 - $39.90
Volume: 33,311
Avg Vol 871,694
Market Cap: $169M
P/E (ttm): 15.50
EPS (ttm): $0.40
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about StemCells.
CAPS Rating 1 out of 5
 
1 Outperform
16 Underperform
CAPS All Stars
 
0 Outperform
14 Underperform

How do you think StemCells will perform against the market?



You pick for StemCells is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


Business Summary

Industry, sector and description for StemCells.

A biopharmaceutical company that operates in one segment, the development of novel cell-based therapeutics designed to treat human diseases and disorders.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Drug Makers